Respiratory Flashcards
Type 1 Respiratory Failure
Low O2, low CO2
Emphysema, astham, pneumonia, pulmonary oedema, PE
Type 2 Respiratory Failure
Low O2, high CO2
Chronic bronchitis, COPD, life-threatening asthma, Guillain-Barre with respiratory failure
Asthma
Chronic inflammatory disorder of the airways. Often with family history of atopy (asthma, allergic rhinitis, eczema). Occupational asthma also present.
Triggers
- URTI, allergens, irritants, drugs (NSAIDs, B-blockers)
Signs
- Dyspnea, wheezing, chest tightness, nocturnal cough, sputum
Partly controlled asthma:
- Daytime: >2/wk
- Night-time: any
- Limitations of activity: any
- Reliever treatment: >2/wk
- Exacerbation: >1/yr
Investigations
- O2 sats
- ABGs
- Pulmonary function test
Treatment:
- Education, avoid triggers
- Pharmacological: SABA, inhaled corticosteroids, LABA, anti-IgE
Hospital admission:
- Require bronchodilator more than 3 hourly
- Persisting oxygen desat at <92%
Emergency management
1) inhaled SABA
2) systemic steroids
3) anticholinergic therapy + Mg
4) intubation in life threatening cases
5) SC adrenaline
6) corticosteroid therapy at discharge
Chronic obstructive pulmonary disease
Progressive and irreversible condition of the lung. 2 types: chronic bronchitis and emphysema
Bronchitis:
- chronic productive cough, purulent sputum, hemoptysis, mild dyspnea
- cyanosis, peripheral edema from cor pulmonale, crackles, wheeze, prolonged expiration
Emphysema:
- dyspnea, minimal cough, tachypnea, decreased exercise tolerance
- pink skin, pursed lip breathing, accessory muscle use, hyperinflation, decreased breath sounds
Treatment
Prolong survival: smoking cessation, vaccination, home oxygen
Symptomatic relief: bronchodilators (SA: ipratropium/salbutamol, LA: tiotropium/salmeterol), corticosteroids, lung transplant.
Acute exacerbations of COPD
- Causes: viral URTI, bacteria, air pollution, CHF, PE, MI
- Management: O2 (88-92% for CO2 retainers), bronchodilators, systemic corticosteroids, antibiotics (amoxicillin, cefaclor, erythromycin)
- ICU admission for life threatening exacerbations
Complications:
- Polycythemia secondary to hypoxemia
- Pulmonary HTN due to vasoconstriction
- Cor pulmonale
- Pneumothorax
Bronchiectasis
Irreversible dilatation of airways due to inflammatory destruction of airway walls by persistently infected mucous.
P. aeruginosa, S. aureus, H. influenza are common pathogens.
Features: chronic cough, purulent sputum, hemoptysis, recurrent pneumonia, local crackles, wheezes, clubbing.
Treatment:
- Vaccination, influenza, pneumonia
- Abx and inhaled corticosteroids for acute exacerbations
- Chest physiotherapy, breathing exercises, physical exercise
Cystic fibrosis
Chloride transport dysfunction, thick secretions from exocrine glands (lung, pancreas, skin, reproductive organs) and blockage of ducts.
Features: chronic bronchitis, pancreatic insufficiency, diabetes, azoospermia.
Infections: S.aureus, P. aeruginnosa, B. cepacia, Aspergillus fumigatus
Investigations:
- Sweat chloride test >60 mmol/L in children
- PFTs, ABGs, CXR
Treatment
- Chest physiotherapy and postural drainage
- Bronchdilators
- Inhaled mucolytic, hypertonic saline DNase
- Inhaled tobramycin
- Abx: ciprofloxacin
- Pancreatic enzyme replacement
Interstitial lung disease
Inflammatory and/or fibrosing process in the alveolar walls, distortion and destruction of normal alveoli. Associated with lung restriction, decreased lung compliance, impaired diffusion, hypoxemia (V/Q mismatch), pulmonary HTN or cor pulmonale
Features: SOB, nonproductive cough, fine crackles, clubbing, cor pulmonale features
Unknown etiology:
- Idiopathic interstitial pneumonias
- Sarcoidosis
- Langerhans-cell histocytosis
- Pulmonary infiltrates with eosinophilia
Known etiology:
- Systemic rheumatic disorders: scleroderma, RA, SLE, polymyositis, mixed connective disease
- Environmental: hypersensitivity pneumonitis, pneumoconioses
- Drugs/treatment
- Pulmonary vasculitis: Wegener’s granulomatosis, Goodpasture’s syndrome, idiopathic pulmonary hemosiderosis
- Inherited disorders: familial IPF, neurofibromatosis, tuberous sclerosis, Gaucher’s disease
- Alveolar filling disorders: chronic eosinophilic pneumonia, pulmonary alveolar proteinosis
Idiopathic pulmonary fibrosis
Progressive, irriversible fibrosis of the lung parenchyma with no known cause.
Features: commonly presents >50 yrs with SOB and dry cough
Causative agents of interstitial lung disease
Hypersensitivity pneumonitis
- extrinsic allergic alveolitis, due to sensitisation to inhaled agents.
- Farmer’s lungs, Bird Fancier’s lung, Humidifier lung
- Presents 4-6h after exposure in acute, insidious onset in chronic presentation.
Pneumoconioses
- Reaction to inhaled organic dust
- Asbestosis: lower lobes, calcified pleural plaques, round atelectasis, mesothelioma
- Silicosis: upper lobes, nodular disease
- Coal worker’s pneumoconiosis: upper lobe, coal macule
Drug induced ILD
- Antineoplastic: methotrexate, cyclophosphamide, chlorambucil
- Antibiotics: nitrofurantoin, penicillin, sulfonamide
- Cardiovascular: amiodarone
- Illicit: heroin, methadone
Radiation-induced
- early pneumonitis ~wks
- late fibrosis 6-12 months
Sarcoidosis
Idiopathic non-infectious granulomatous multisystem with lung involvement.
Features: cough, dyspnea, fever, arthralgia, malaise, erythema nodosum, chest pain.
Investigations:
- FBC
- Serum U&E, Ca (vit D activation by granulomas)
- Elevated ACE
- CXR predominantly nodular opacities in upper lung zones + bilar adenopathy
- PFT
Diagnosis:
- Biopsy
Treatment:
- Earlier stages may resolve spontaneously
- Steroids, methotrexate and other immunosuppressives may be used
Pulmonary hypertension
MAP of pulmonary artery >25 mmHg or systolic >40 mmHg.
Mechanisms:
Hypoxic vasoconstriction - down regulation of NO synthase and alteration of endothelium leading to vasoconstriction
Decreased area of pulmonary vascular bed - rise in resting pulmonary arterial pressure
Volume and pressure overload - excessive volume overload.
Classifications
I) Pulmonary arterial HTN - idiopathic, collagen vascular disease, Eisenmenger syndrome, portopulmonary HTN, HIV infection, sickle cell disease
II) Pulmonary HTN due to left heart disease - LV dysfunction, aortic stenosis, mitral stenosis
III) Pulmonary HTN due to lung disease/hypoxia - parenchymal lung disease, chronic alveolar hypoxia
IV) Chronic thromboembolic pulmonary HTN - thromboembolic obstruction of pulmonary arteries
V) Pulmonary HTN with unclear mechanisms - hematologic disorders, systemic, metabolic disorders
Idiopathic pulmonary arterial hypertension
Features: young women 20-40yrs, sporadic, present with dyspnea, fatigue, syncope, exertional chest pain , Raynaud’s pheonmenon.
Investigations:
- CXR: enlarged central pulmonary arteries
- ECG: RVH/strain
- Cardiac catheterization
Treatment:
- Trial of CCB
Prognosis:
- 2-3yr mean survival
Pulmonary embolism
Risk factors:
- Stasis: immobilisation, obesity, CHF, chronic venous insufficiency
- Endothelial damage: post-operative, trauma
- Hypercoagulable states: malignancy, cancer treatment, estrogen, pregnancy, prior DVT/PE, nephrotic syndrome, coagulopathies, increasing age
Investigations:
- Pulmonary angiogram
- D-dimer
- CT angiogram
- Venous duplex US or Doppler
- ECG (S1Q3T3)
- CXR (atelectasis, pleural effusion
Treatment
- Oxygen
- Analgesia
- Acute anticoagulation: IV heparin, enoxapain
- Long term anticoagulation: warfarin, enoxaparin (pregnancy, active cancer)
- IV thrombolytic therapy/interventional thrombolytic therapy,
- IVC filter for absolute CI to anticoagulants
Thromboprophylaxis
- LMWH
- Fonaparinux
- Warfarin
- Dabigatran
- Heparin
- TED stockings
Pulmonary vasulitis
Wegner’s Granulomatosis
- systemic vasculitis of med/small arteries
- necrotising granulomatous lesions of upper and lower resp tract
- GN, focal necrotising lesions
- C-ANCA positive
Churg-Strauss Syndrome
- multisystem disorder characterised by allergic rhinitis, asthma, prominent peripherla eosinophilia
- asthma, infiltrates
- life threatening systemic vasculitis
Goodpasture’s Disease
- disorder chrarcterised by diffuse alveolar hemorrhage and glomerulonephritis (anti-GBM antibodies)
- hemoptysis
- anemia, glomerulonephritis
SLE
RA
Scleroderma
Mediatinal masses
Anterior compartment
- Thymoma
- Thyroid enlargement
- Teratoma
- Thoracic aneurysm
- Tumours: lymphoma, parathyroid, esophageal angiomatous
Middle compartment
- Pericardial cyst
- Bronchogenic cyst/tumour
- Lymphoma
- Lymph node enlargment
- Aortic aneurysm
Posterior compartment
- Neurogenic tumours
- Meningocele
- Enteric cysts
- Lymphoma
- Diaphragmatic hernias
- Esophageal tumour
- Aortic aneurysm
Signs
- Asymptomatic 50%
- Chest pain, cough, dyspnea, recurrent respiratory infections
- Hoarseness, dysphagia, Horner’s syndrome, SVC compression
- Paraneoplastic syndromes (myarthenia gravis)